On October 15, 2021, National Medical Products Administration (NMPA) Centre for Drug Evaluation (CDE) is calling for comment until 15 Nov 2021 on Technical Guiding Principles on Human-specific Immunoglobulin Pharmaceutical Research and Evaluation. 

The document's main contents cover:

   - Summary 
   - Scope of application
   - General principles 
   - Pharmaceutical research and evaluation key points 
   - Terminology 

   - References 

If you need more information or any help on the topic, please contact:

assistant@bestao-consulting.com